Societies aim to open TAVR to more patients

02/14/2013 | Forbes · CardiovascularBusiness.com

The Society of Thoracic Surgeons and the American College of Cardiology have received investigational device exemption approval to conduct a clinical study evaluating broader use of transcatheter aortic valve replacement. This marks the first time medical societies have pursued an IDE, according to SCAI trustee Dr. Ralph Brindis. "The goal of the effort is to gain reimbursement for an expanded set of procedures with Sapien to make the device accessible to more patients," he said. The groups are now pursuing FDA approval for two more studies in hopes of expanding the uses of transcatheter aortic valve replacement.

View Full Article in:

Forbes · CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN